PolarCool extends agreement with BrainCool regarding quality assurance
PolarCool AB (publ) and BrainCool AB (publ) have extended a cooperation agreement in relation to the quality assurance of the company's medical technology product, PolarCap® System, which will continue to be manufactured and sold under BrainCool's quality system (QMS). The renewed agreement runs until December 31, 2023. PolarCool develops and markets the product PolarCap System, which alleviates the effects of concussion. The primary users of PolarCap include sports clubs, organizations, and facilities in contact sports such as ice hockey, rugby, football and handball, but also other